Category: Hospitals
Announcing The New and Improved Concert Platform

Latest update adds insurance coverage information and other enhancements to the market’s leading genetic test order management platform Earlier today, we announced the release of the latest version of our genetic test ordering management system – The Concert Platform (formerly GeneConnect®) – adding compelling new capabilities to a platform used by leading hospitals and health […]


Thu. February 8, 2018
Read Post
Press Release: Oregon Health & Science University Engages GeneConnect® Genetic Test Utilization Management Solution

NASHVILLE, Tenn. (July 13, 2016) — NextGxDx Inc. (*now Concert Genetics) today announced an agreement with Oregon Health & Science University (OHSU) to deliver GeneConnect®, the genetic test utilization management solution that enables healthcare institutions to lower the costs and address the workflow inefficiencies associated with genetic test ordering. “Genetic testing is the key to […]


Wed. July 13, 2016
Read Post
Press Release: Dartmouth-Hitchcock Medical Center Engages GeneConnect® Genetic Test Utilization Management Solution

NASHVILLE, Tenn. (June 1, 2016) — NextGxDx Inc. (*now Concert Genetics) today announced an agreement with Dartmouth-Hitchcock Medical Center to deliver GeneConnect®, the genetic test utilization management solution that enables healthcare institutions to lower the costs and address the workflow inefficiencies associated with genetic test ordering. “Genetic testing is the lynchpin of personalized medicine, but […]


Wed. June 1, 2016
Read Post
Webinar from PreventionGenetics – Deletions and Duplications: Why They’re Important and How to Get the Most Accurate Results for Your Patients

This week, our colleagues at PreventionGenetics will be hosting a webinar about testing for deletions and duplications. Knowing this is a pertinent topic to many of our readers, we’re pleased to share details about their event. It’s a free session featuring Laboratory Director Dr. Diane Allingham-Hawkins. Register here. A webinar from: Deletions and Duplications: Why They’re Important and How […]


Tue. April 12, 2016
Read Post
The Promise of Data Science and the Challenges of the Clinical Workflow (notes from #PMWC16)

One of the most exciting things to behold at this year’s Personalized Medicine World Conference  is the increasingly innovative ways that companies and healthcare providers are combining disparate data sources and deploying analytic tools to generate insights that are useful and actionable for clinicians. This is no small feat. It won’t surprise anyone reading this […]


Wed. January 27, 2016
Read Post
Press Release: Cincinnati Children’s Engages GeneConnect® Genetic Test Utilization Management Solution

NASHVILLE, Tenn. (December 21, 2015) — NextGxDx Inc. (*now Concert Genetics) today announced an agreement with Cincinnati Children’s Hospital Medical Center to deliver GeneConnect®, the genetic test utilization management solution that enables healthcare institutions to create genetic testing formularies that can lower the costs and address the workflow inefficiencies associated with genetic test ordering. “Genetic […]


Mon. December 21, 2015
Read Post
Genetic analysis reveals defective protein leading to mitral valve prolapse

By: David Shifrin, PhD Science Writer, Filament Life Science Communications Another small but important piece has been fitted in to the endless puzzle of genetic predisposition to disease. This time, a gene responsible for a cardiac condition found in ~2% of individuals has been uncovered by researchers at Massachusetts General Hospital. Mitral valve prolapse (MVP) has […]


Tue. December 15, 2015
Read Post
Naming Conventions and Charcot-Marie-Tooth Disease

By: David Shifrin, PhD Science Writer, Filament Life Science Communications We all know the feeling: A new project starts, so we set up a folder system and naming convention and get to work. It works pretty well for a while; most of the files fit into the folder hierarchy on our computer and the names generally […]


Tue. October 27, 2015
Read Post
Press Release: Novation Awards Group Purchasing Agreement to NextGxDx for the Members of Children’s Hospital Association

GeneConnect™ genetic testing utilization software supports management of rapidly rising genetic testing costs NASHVILLE, Tenn., Sept. 16, 2015 /PRNewswire/ — Novation, the nation’s largest healthcare services organization, has awarded a group purchasing contract to Franklin, Tennessee-based NextGxDx, Inc. (*now Concert Genetics) Under the agreement, Children’s Hospital Association (CHA) members who participate with Novation will have […]


Wed. September 16, 2015
Read Post
Closing the gap between the promise and reality of genetic testing: Is data sharing the answer?

By: David Shifrin, PhD Science Writer, Filament Life Science Communications These days, there is a significant push in parts of the genetics community to share testing results. One of the organizations spearheading this effort is Free the Data, which focuses on getting patients to contribute their BRCA1/2 sequences to an anonymized database for use in research. […]


Tue. August 4, 2015
Read Post
Opinions on Genetic Testing from the Early Adopters

By: David Shifrin, PhD Science Writer, Filament Life Science Communications The past few weeks have been filled with articles dealing with the distribution and use of genetic test results. As we have pointed out on this blog, the underlying theme is that gaining a full(er) understanding of the clinical implications of any given genetic variant will […]


Wed. July 1, 2015
Read Post
Press Release: NextGxDx and Seattle Children’s Hospital’s PLUGS® Program Collaborate on Comprehensive Genetic Testing Utilization Management Solution

PLUGS clinical and UM content to be distributed through GeneConnect™ platform SEATTLE, June 25, 2015 /PRNewswire/ — Seattle Children’s Hospital today announced that it will collaborate with NextGxDx, Inc. (*now Concert Genetics) to develop a joint genetic test utilization management (UM) solution for children’s hospitals and pediatric practices. The collaboration will combine the hospital’s PLUGS […]


Thu. June 25, 2015
Read Post
Panel Testing, Part 3: Recommended Use for Panel Tests

By: David Shifrin, PhD Science Writer, Filament Life Science Communications Last September, The National Comprehensive Cancer Network published an update to their guidelines for Genetic/Familial High-Risk Assessment for Breast and Ovarian cancers. This extensive document included a large section discussing the use of multi-gene panel testing. Again highlighting the uncertainty and concern, the first paragraph of […]


Tue. June 2, 2015
Read Post
Panel Testing Part 1: The genetics arm race leads to clinical questions

By: David Shifrin, PhD Science Writer, Filament Life Science Communications Bundling. It’s done in practically every industry, from adding optional features on a new car, to internet and phone service, to academic journal subscriptions. Medicine is no exception. These days, bundling is common in the world of genetic testing. The use of panel tests has increased […]


Thu. May 14, 2015
Read Post
New Recommendations for Prenatal Genetic Testing

By: David Shifrin, PhD Life Science Consultant and Freelance Writer The European Society of Human Genetics (ESHG) and the American Society of Human Genetics (ASHG) have released new recommendations for prenatal testing. At the center of the discussion and recommendations is the use of non-invasive prenatal testing (NIPT) as a complement or alternative to procedures […]


Thu. April 30, 2015
Read Post